Cargando…

Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line

L-Asparaginase (ASNase) is a biopharmaceutical used as an essential drug in the treatment of acute lymphoblastic leukemia (ALL). Yet, some cases of ALL are naturally resistant to ASNase treatment, which results in poor prognosis. The REH ALL cell line, used as a model for studying the most common su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Iris Munhoz, Effer, Brian, Costa-Silva, Tales Alexandre, Chen, Chen, Ciccone, Michael F., Pessoa, Adalberto, dos Santos, Camila O., Monteiro, Gisele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342508/ https://www.ncbi.nlm.nih.gov/pubmed/37446393 http://dx.doi.org/10.3390/ijms241311215

Ejemplares similares

Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity
por: Costa, Iris Munhoz, et al.
Publicado: (2016)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems
por: Lefin, Nicolás, et al.
Publicado: (2023)

Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles
por: Brumano, Larissa Pereira, et al.
Publicado: (2019)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Induction of Cell Death in the Human Acute Lymphoblastic Leukemia Cell Line Reh by Infection with Rotavirus Isolate Wt1-5
por: Guerrero, Rafael, et al.
Publicado: (2020)

L-Asparaginase induced thrombosis in acute lymphoblastic leukemia
por: Kulkarni, Ketan P.
Publicado: (2012)

Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
por: Hijiya, Nobuko, et al.
Publicado: (2016)

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
por: Egler, Rachel A., et al.
Publicado: (2016)

L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study
por: dos Santos, Amanda Cabral, et al.
Publicado: (2021)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
por: M'harzi, Soulaimane, et al.
Publicado: (2022)

Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH
por: Lysenkova Wiklander, Mariya, et al.
Publicado: (2023)

Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022)

Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia
por: Avramis, Vassilios I, et al.
Publicado: (2006)

L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia
por: Saburi, Masuho, et al.
Publicado: (2020)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
por: Schmidt, Madalina-Petronela, et al.
Publicado: (2021)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
por: Chenbah, Wafa, et al.
Publicado: (2023)

Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2013)

Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
por: Andrade, Augusto F, et al.
Publicado: (2014)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
por: Sassen, Sebastiaan D.T., et al.
Publicado: (2017)

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
por: Juluri, Krishna R, et al.
Publicado: (2022)

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
por: Vrooman, Lynda M., et al.
Publicado: (2015)

Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019)

Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
por: Dai, Zhan-Jing, et al.
Publicado: (2021)

Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report
por: Tanaka, Ryuma, et al.
Publicado: (2012)

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
por: Koprivnikar, Jamie, et al.
Publicado: (2017)

The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL)
por: Aisyi, Mururul, et al.
Publicado: (2019)

Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
por: Jameel, Patel Zeeshan, et al.
Publicado: (2020)

Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach
por: Baral, Adesh, et al.
Publicado: (2021)

Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic Leukemia
por: Lee, Shawn H. R., et al.
Publicado: (2023)

Correction: Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019)

Acute Pancreatitis and Diabetic Ketoacidosis following L-Asparaginase/Prednisone Therapy in Acute Lymphoblastic Leukemia
por: Quintanilla-Flores, Dania Lizet, et al.
Publicado: (2014)

L-asparaginase fatal toxic encephalopathy during consolidation treatment in an adult with acute lymphoblastic leukemia
por: Frantzeskaki, Frantzeska, et al.
Publicado: (2013)

Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
por: Boissel, Nicolas, et al.
Publicado: (2015)

Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia
por: Underwood, Brynne, et al.
Publicado: (2020)

BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway
por: Butler, Miriam, et al.
Publicado: (2021)

Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana
por: Osei-OWusu, William, et al.
Publicado: (2021)

Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia
por: Nielsen, Rikke L., et al.
Publicado: (2022)

Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
por: Liu, Wen-jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_im0pk5i237n1s8vftvghfcj3u4